Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways

International Journal of Molecular Sciences

Volumn 12, Issue 8, 2011, Pages 5213-5237

  Doi, Kunio ^a,b   Uetsuka, Koji ^a  

^a NIPPON INSTITUTE FOR BIOLOGICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Fumonisin B 1; Macrocyclic trichothecenes; Neurotoxicity; Ochratoxin A; T 2 toxin

Indexed keywords

CASPASE 3; FUMONISIN B1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROCYCLIC COMPOUND; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYCOTOXIN; OCHRATOXIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; T 2 TOXIN; TRICHOTHECENE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; FUMONISIN; NEUROTOXIN;

APOPTOSIS; BAX ALPHA GENE; BINDING AFFINITY; CASPASE 2 GENE; CASPASE 9 GENE; CELL DEATH; DNA FRAGMENTATION; ENZYME ACTIVATION; GENE; GENE EXPRESSION REGULATION; HUMAN; LIPID METABOLISM; LIPID PEROXIDATION; MEKK1 GENE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; P53 GENE; PROTEIN BINDING; PROTEIN SYNTHESIS INHIBITION; REVIEW; SIGNAL TRANSDUCTION; SINGLE STRANDED DNA BREAK; TOXICITY TESTING; ANIMAL; DRUG EFFECTS; TOXICITY;

RODENTIA;

ANIMALS; FUMONISINS; HUMANS; MYCOTOXINS; NEUROTOXINS; OCHRATOXINS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; T-2 TOXIN; TRICHOTHECENES;

EID: 80052166940     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12085213     Document Type: Review

References (196)

1. Haschek, W.M.; Voss, K.A.; Beasley, V.R. Selected Mycotoxins Affecting Animal and Human Health. In Handbook of Toxicologic Pathology; Haschek, W.M., Rousseaux, C.G., Walling, M.A., Eds.; Academic Press: San Diego, CA, USA, 2002; pp. 645-699.
2. Surai, P.F.; Mezes, M.; Melnichuk, S.D.; Fotina, T.I. Mycotoxins and animal health: From oxidative stress to gene expression. Krmiva 2008, 50, 35-43.
3. Chandra, J.; Samali, A.; Orrenius, S. Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med. 2000, 29, 323-333.
4. Desjardins, A.E.; Hohn, T.M.; McComic, S.P. Trichothecene biosynthesis in Fusarium species: chemistry, genetics, and significance. Microbiol. Mol. Biol. Rev. 1993, 57, 595-604.
5. Nelson, P.E.; Dignani, M.C.; Anaissie, E.J. Taxonomy, biology, and clinical aspects of Fusarium species. Clin. Microbiol. Rev.1994, 7, 479-504.
6. Joffe, A.Z. Foodborne Diseases: Alimentary Toxic Aleukia. In Handbook of Foodborne Diseases of Biological Origin; Rochcigle, M., Ed.; CRC Press: Boca Raton, FL, USA, 1983; pp. 353-495.
7. Saito, M.; Ohtsubo, K. Trichothecene Toxins of Fusarium Species. In Mycotoxins; Purchase, I.F.H., Ed.; Elsevier Scientific Publication: New York, NY, USA, 1977; pp. 264-280.
8. Ueno, Y.; Ishii, K.; Saki, K.; Kanadera, K.; Tsunoda, S.; Tanoka, H.; Enomoto, M. Toxicological approaches to the metabolites of fusaria. IV. Microbial survey on "bean-hulls poisoning of horses" with the isolation of toxic trichothecenes, neosonaniol and T-2 toxin of Fusarium solani M-1-1. Jpn. J. Exp. Med.1972, 42, 187-203.
9. Bennet, J.W.; Klich, M. Mycotoxins. Clin. Microbiol. Rev. 2003, 16, 497-516.
10. Eriksen, G.S.; Petterson, H. Toxicological evaluation of trichothecenes in animal feed. Anim. Feed Sci. Technol. 2004, 114, 205-239.
11. Shifrin, V.I.; Anderson, P. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J. Biol. Chem.1999, 274, 13985-13992.
12. Chang, I.M.; Mar, W.C. Effect of T-2 toxin on lipid peroxidation in rats: Elevation of conjugated diene formation. Toxicol. Lett. 1988, 40, 275-280.
13. Eriksen, G.S.; Petterson, H.; Lund, H. Comparative cytotoxicity of deoxynivalenol, nivalenol, triacetylated derivatives and de-epoxy metabolites. Food Chem. Toxicol. 2004, 42, 619-624.
14. IARC. Toxins derived from Fusarium sporotrichoides: T-2 toxin. In IARC Monographson the Evaluation of Carcinogenic Risks to Humans; IARC: Lyon, France, 1993; pp. 467-488.
15. Sharma, R.P. Immunotoxicity of mycotoxins. J. Dairy Sci. 1993, 76, 892-897.
16. Stanford, G.K.; Hood, R.D.; Haynes, A.W. Effects of prenatal administration of T-2 toxin to mice. Res. Commu. Chem. Pathol. Pharmacol.1975, 10, 743-746.
17. Williams, P.P. Effects of T-2 mycotoxin on gastrointestinal tissues: A review of in vivo and in vitro models. Arch. Environ. Contam. Toxicol.1989, 18, 374-387.
18. Shinozuka, J.; Li, G.; Kiatipattanasakul, W.; Uetsuka, K.; Nakayama, H.; Doi, K. T-2 toxin-induced apoptosis in lymphoid organs of mice. Exp. Toxicol. Pathol. 1997, 49, 387-392.
19. Li, G.; Shinozuka, J.; Uetsuka, K.; Nakayama, H.; Doi, K. T-2 toxin-induced apoptosis in Peyer's patches of mice. J. Toxicol. Pathol. 1997, 10, 59-61.
20. Shinozuka, J.; Suzuki, M.; Noguchi, N.; Sugimoto, T.; Uetsuka, K.; Nakayama, H.; Doi, K. T-2 toxin-induced apoptosis in hematopoietic tissues of mice. Toxicol. Pathol. 1998, 26, 674-681.
21. Li, G.; Shinozuka, J.; Uetsuka, K.; Nakayama, H.; Doi, K. T-2 toxin-induced apoptosis in intestinal crypt epithelial cells of mice. Exp. Toxicol. Pathol. 1997, 49, 447-450.
22. Albarenque, S.M.; Shinozuka, J.; Iwamoto, S.; Nakayama, H.; Doi, K. T-2 toxin-induced acute skin lesions in Wistar-derived hypotrichotic WBN/ILA-Ht rats. Histol. Histopathol. 1999, 14, 337-342.
23. Shinozuka, J.; Miwa, S.; Fujimura, H.; Toriumi, W.; Doi, K. Hepatotoxicity of T-2 Toxin, Trichothecene Mycotoxin. In New Strategies for Mycotoxin Research in Asia (Proceedings of ISMYCO Bangkok '06); Kumagai, S., Ed.; Japanese Association of Mycotoxicology: Tokyo, Japan, 2007; pp. 62-66.
24. Sehata, S.; Kiyosawa, N.; Atsumi, F.; Ito, K.; Yamoto, T.; Teranishi, M.; Uetsuka, K.; Nakayama, H.; Doi, K. Microarray analysis of T-2 toxin-induced liver, placenta and fetal liver lesions in pregnant rats. Exp. Toxicol. Pathol. 2005, 57, 15-28.
25. Doi, K.; Shinozuka, J.; Sehata, S. T-2 toxin and apoptosis. J. Toxicol. Pathol. 2006, 19, 15-27.
26. Doi, K.; Ishigami, N.; Sehata, S. T-2 toxin-induced toxicity in pregnant mice and rats. Int. J. Mol. Sci. 2008, 9, 2146-2158.
27. Chaudhary, M.; Rao, P.V. Brain oxidative stress after dermal and subcutaneous exposure of T-2 toxin in mice. Food Chem. Toxicol. 2010, 48, 3436-3442.
28. Boyd, K.E.; Fitzpatrick, D.W.; Wilson, J.R.; Wilson, L.M. Effect of T-2 toxin on brain biogenic monoamines in rats and chickens. Can. J. Vet. Res. 1988, 52, 181-185.
29. Martin, L.J.; Morse, J.D.; Anthony, A. Quantitative cytophotometric analysis of brain neuronal RNA and protein changes in acute T-2 mycotoxin poisoned rats. Toxicon 1986, 24, 933-941.
30. Wang, J.; Fitzpatrick, D.W.; Wilson, J.R. Effects of the trichothecene mycotoxin T-2 toxin on neurotransmitters and metabolites in discrete areas of the rat brain. Food Chem. Toxicol. 1998, 36, 947-953.
31. Wang, J.; Fitzpatrick, D.W.; Wilson, J.R. Effect of T-2 toxin on blood-brain barrier permeability monoamine oxidase activity and protein synthesis in rats. Food Chem. Toxicol. 1998, 36, 955-961.
32. Ishigami, N.; Shinozuka, J.; Katayama, K.; Uetsuka, K.; Nakayama, H.; Doi, K. Apoptosis in the developing mouse embryos from T-2 toxin-inoculated dams. Histol. Histopathol. 1999, 14, 729-733.
33. Ishigami, N.; Shinozuka, J.; Katayama, K.; Uetsuka, K.; Nakayama, H.; Doi, K. Apoptosis in mouse fetuses from dams exposed to T-2 toxin at different days of gestation. Exp. Toxicol. Pathol. 2001, 52, 493-501.
34. Rousseaux, C.G.; Schiefer, H.B. Maternal toxicity, embryolethality and abnormal fetal development in CD-1 mice following one oral dose of T-2 toxin. J. Appl. Toxicol. 1987, 7, 281-288.
35. Stanford, G.K.; Hood, R.D.; Hayes, A.W. Effect of prenatal administration of T-2 toxin to mice. Res. Commun. Chem. Path. Pharmacol. 1975, 10, 743-746.
36. Sehata, S.; Kiyosawa, N.; Makino, T.; Atsumi, F.; Ito, K.; Yamoto, T.; Teranishi, M., Baba, Y.; Uetauka, K.; Nakayama, H.; Doi, K. Morphological and microarray analysis of T-2 toxin-induced rat fetal brain lesion. Food Chem. Toxicol. 2004, 42, 1727-1736.
37. Galtier, P.; Paulin, F.; Eeckhoutte, C.; Larrieu, G. Comparative effects of T-2 toxin and diacetoxyscirpenol on drug metabolizing enzymes in rat tissues. Food Chem. Toxicol. 1989, 27, 215-220.
38. Guerre, P.; Eeckhoutte, C.; Burgat, V.; Galtier, P. The effects of T-2 toxin exposure on liver drug metabolizing enzymes in rabbit. Food Add. Contam. 2000, 17, 1019-1026.
39. Jarpe, M.B.; Widmann, C.; Knall, C.; Schlesinger, T.K.; Gibson, S.; Yujiri, T.; Fanger, G.R.; Gelfand, E.W.; Johnson, G.L. Anti-apoptotic versus pro-apoptotic signal transduction: checkpoints and stop signs along the roard to death. Oncogene1998, 17, 1475-1582.
40. Bold, S.; Weidle, U.H.; Kolch, W. The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathways. Exp. Cell Res. 2003, 283, 80-90.
41. Ham, J.; Eilers, A.; Whitfield, J.; Neame, S.J.; Shah, B. c-JUN and the transcriptional control of neuronal apoptosis. Biochem. Pharmacol. 2000, 60, 1015-1021.
42. Annunziato, L.; Amoroso, S.; Pannaccione, A.; Cataldi, M.; Pignataro, G.; D'Alessio, S.; Sirabella, R.; Second, A.; Sibaud, L.; DiRenzo, G.F. Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. Toxicol. Lett. 2003, 139, 125-133.
43. Troy, C.M.; Shelanski, M.L. Caspase-2 redux. Cell Death Differ. 2003, 10, 101-107.
44. Huang, P.; Akagawa, K.; Yokoyama, Y.; Nohara, K.; Kano, K.; Morimoto, K. T-2 toxin initially activates caspase-2 and induces apoptosis in U937 cells. Toxicol. Lett. 2007, 170, 1-10.
45. Kanemitsu, H.; Yamauchi, H.; Komatsu, M.; Yamamoto, S.; Okazaki, S.; Uchida, K.; Nakayama, H. 6-Mercaptopurine (6-MP) induces cell cycle arrest and apoptosis of neural progenitor cells in the developing rat brain. Neurotox. Teratol. 2009, 31, 104-109.
46. Katayama, K.; Ueno, M.; Yamauchi, H.; Nakayama, H.; Doi, K. Microarray analysis of genes in fetal central nervous system after ethylnitrosourea administration. Birth Defects Res. Part B 2005, 74, 255-260.
47. Nam, C.; Yamauchi, H.; Nakayama, H.; Doi, K. Etoposide induces apoptosis and cell cycle arrest of neuroepithelial cells in a p53-related manner. Neurotox. Teratol. 2009, 28, 664-672.
48. Ueno, M.; Katayama, K.; Yamauchi, H.; Nakayama, H.; Doi, K. Cell cycle and cell death regulation of neural progenitor cells in the 5-azacytidine (5AzC)-treated developing fetal brain. Exp. Neurol.2006, 198, 154-166.
49. Woo, G.H.; Bak, E.J.; Nakayama, H.; Doi, K. Molecular mechanisms of hydroxyurea (HU)-induced apoptosis in the mouse fetal brain. Neurotox. Teratol. 2006, 28, 125-134.
50. Ogunshola, O.O.; Antic, A.; Donoghue, M.J.; Fan, S.-Y.; Kim, H.; Stewart, W.B.; Madri, J.A.; Ment, L.R. Paracrine and autocrine function of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J. Biol. Chem. 2002, 277, 11410-11415.
51. Halliwell, B.; Gutteridge, J.M.C. Free Radicals in Biology and Medicine, 3rd ed.; Oxford University Press: New York, NY, USA, 1999.
52. Lee, J.-M.; Jiang, L.; Johnson, D.A.; Stein, T.D.; Kraft, A.D.; Calkins, M.J.; Jakel, R.J.; Jofnson, J.A. Nrf2, a multiorgan protector? FASEB J. 2005, 19, 1061-1066.
53. Boesch-Saadatmandi, C.; Wagner, A.E.; Graeser, A.C.; Hundhausen, C.; Wollram, S.; Rimbach, G. Ochratoxin A impairs Nrf2-dependent gene expression in porcine kidney tubulus cells. J. Anim. Phys. Anim. Nutr. 2009, 93, 547-555.
54. Boutin-Forzano, S.; Charpin-Kadouch, C.; Chabbi, S.; Bennedjai, N.; Dumon, H.; Charpin, D. Wall relative humidity: A simple and reliable index for predicting Stachybotrys chartarum infestation in dwellings. Indoor Air 2004, 14, 196-199.
55. Tsumori, T.; Reijula, K.; Johnsson, T.; Hemminki, K.; Hintikka, E.L.; Lindroos, O.; Kalso, S.; Koukila-Kahkola, P.; Mussalo-Rauhamaa, H.; Haahtela, T. Mycotoxins in crude building materials from water-damaged buildings. Appl. Environ. Microbiol. 2000, 66, 1899-1904.
56. Pestka, J.J.; Yike, I.; Dearborn, D.G.; Ward, M.D.W.; Harkema, J.R. Stachybotrys chartarum, trichothecene mycotoxins, and damp building-related illness: New insights into a public health enigma. Toxicol. Sci. 2008, 104, 4-26.
57. Shelton, B.G.; Kirkland, K.H.; Flanders, W.D.; Morris, G.K. Profiles of airborne fungi in buildings and outdoor environments in the United States. Appl. Environ. Microbiol. 2002, 68, 1743-1753.
58. Hodgson, M.J.; Morey, P.; Leung, W.Y.; Morrow, L.; Miller, D.; Jarvis, B.B.; Robbins, H.; Halsey, J.F.; Storey, E. Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J. Occup. Environ. Med. 1998, 40, 241-249.
59. Johanning, E.; Biagini, R.; Hull, D.; Morey, P.; Jarvis, B.; Landsbergis, P. Health and immunology study following exposure to toxigenic fungi (Stachybotrys chartarum) in a water-damaged office environment. Int. Arch. Occup. Environ. Health 1996, 68, 207-218.
60. Gordon, W.A.; Cantor, J.B.; Johanning, E.; Charatz, H.J.; Ashman, T.A.; Breeze, J.L.; Haddad, L.; Abramowitz, S. Cognitive impairment associated with toxigenic fungal exposure: A replication and extension of previous findings. Appl. Neuropsychol. 2004, 11, 65-74.
61. Hossain, M.A.; Ahmed, M.S.; Ghannoum, M.A. Attributes of Stachybotrys chartarum and its association with human disease. J. Allergy Clin. Immunol. 2004, 113, 200-208.
62. Kirburn, K.H. Role of molds and myxotoxins in being sick in buildings: Neurobehavioral and pulmonary impairment. Adv. Appl. Microbiol. 2004, 55, 339-359.
63. Andersen, B.; Nielsen, K.F.; Jarvis, B.B. Characterization of Stachybotrys from water-damaged buildings based on morphology, growth, and metabolite production. Mycologia 2002, 94, 392-403.
64. Gregory, L.; Pestka, J.J.; Dearborn, D.G.; Rand, T.G. Localization of satratoxin-G in Stachybotrys chartarum spores and spore-impacted mouse lung using immunocytochemistry. Toxicol. Pathol. 2004, 32, 26-34.
65. Yike, I.; Distler, A.M.; Ziady, A.G.; Dearborn, D.G. Mycotoxin adducts on human serum albumin: Biomerkers of exposure to Stachybotrys chartarum. Environ. Health Perspect. 2006, 114, 1221-1226.
66. Chung, Y.J.; Zhou, H.R.; Pestka, J.J. Transcriptional and posttranscriptional roles for p38 mitogen-activated protein kinase in upregulation of TNF-α expression by deoxynivalenol (vomitoxin). Toxicol. Appl. Pharmacol. 2003, 193, 188-201.
67. Moon, Y.; Pestka, J.J. Deoxynivalenol-induced mitogen-activated protein kinase phosphorylation and IL-6 expression in mice suppressed by fish oil. J. Nutr. Biochem. 2003, 14, 717-726.
68. Zhou, H.R.; Lau, A.S.; Pestka, J.J. Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenol-induced ribotoxic stress response. Toxicol. Sci. 2003, 74, 335-344.
69. Iordanov, M.S.; Pribnow, D.; Magun, J.L.; Dinh, T.H.; Pearson, J.A.; Chen, S.L.; Magun, B.E. Ribotoxic stress response: Activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alphasarcin/ricin loop in the 28S rRNA. Mol. Cell Biol. 1997, 17, 3373-3381.
70. Chung, Y.J.; Jarvis, B.; Pestka, J.J. Modulation of lipopolysaccharide-induced proinflammatory cytokine production by satratoxins and other macrocyclic trichothecenes in the murine macrophage. J. Toxicol. Environ. Health A 2003, 66, 379-391.
71. Chung, Y.J.; Yang, G.H.; Islam, Z.; Pestka, J.J. Up-regulation of macrophage inflammatory protein-2 and complement 3A receptor by the trichothecenes deoxynivalenol and satratoxin G. Toxicology 2003, 186, 51-65.
72. Hughes, B.J.; Hsieh, G.C.; Jarvis, B.B.; Sharma, R.P. Effects of macrocyclic trichothecene mycotoxins on the murine immune system. Arh. Environ. Contam. Toxicol. 1989, 18, 388-395.
73. Hughes, B.J.; Jarvis, B.B.; Sharma, R.P. Effects of macrocyclictrichothecene congeners on the viability and mitogenesis of mirine splenic lymphocytes. Toxicol. Lett.1990, 50, 57-67.
74. Pestka, J.J.; Forsell, J.H. Inhibition of human lymphocyte transformation by the macrocyclic trichothecene roridin A and verrucarin A. Toxicol. Lett.1988, 41, 215-222.
75. Yang, G.-H.; Jarvis, B.B.; Chung, Y.-J.; Pestka, J.J. Apoptosis induction by the satratoxins and other trichothecene mycotoxins: relationship to ERK, p38 MAPK, and SAPK/JNK activation. Toxicol. Appl. Pharmacol. 2000, 164, 149-160.
76. Cundliffe, E.; Davies, J.E. Inhibition of initiation, elongation, and termination of eukaryotic protein synthesis by trichothecene fungal toxins. Antimicrob. Agents Chemother. 1977, 11, 491-499.
77. Nielsen, K.F.; Huttunen, K.; Hyvarinen, A.; Andersen, B.; Jarvis, B.B.; Hirvonen, M.R. Metabolite profiles of Stachybotrys isolates from water-damaged buildings and their induction of inflammatory mediators and cytotoxicity in macrophages. Mycopathologia 2002, 154, 201-205.
78. Islam, Z.; Shinozuka, J.; Harkema, J.R.; Pestka, J.J. Purification and comparative neurotoxicity of the trichothecenes satratoxin G and roridin L2 from Stachybotrys chartarum. J. Toxicol. Environ. Health A 2009, 72, 1242-1251.
79. Nusuetrong, P.; Pengsuparp, T.; Meksuriyen, D.; Tanitsu, M.; Kikuchi, H.; Muzugaki, M.; Shimazu, K; Oshima, Y.; Nakahata, N.; Yoshida, M. Satratoxin H generates reactive oxygen species and lipid peroxides in PC12 cell. Biol. Pharm. Bull. 2008, 31, 1115-1120.
80. Rand, T.G.; Mahoney, M.; White, K.; Oulton, M. Microanatomical changes in alveolar type II cells in juvenile mice intratracheally exposed to Stachybotrys chartarum spores and toxin. Toxicol. Sci. 2002, 65, 239-245.
81. Wang, H.; Yadav, J.S. Global gene expression changes underlying Stachybotrys chartarum toxin-induced apoptosis in murine alveolar macrophages: Evidence of multiple signal transduction pathways. Apoptosis 2007, 12, 535-548.
82. Wang, H.; Yadav, J.S. DNA damage, redox changes, and associated stress-inducible signaling events underlying the apoptosis and cytotocity in murine alveolar macrophage cell line MH-S by methanol-extracted Stachybotrys chartarum toxins. Toxicol. Appl. Pharmacol. 2006, 214, 297-308.
83. Islam, Z.; Harkema, J.R.; Pestka, J.J. Satratoxin G from the black mold Stachybotrys chartarum evokes olfactory sensory neuron loss and inflammation in the murine nose and brain. Environ. Health Perspect. 2006, 114, 1099-1107.
84. Islam, Z.; Amuzie, C.J.; Harkema, J.R.; Pestka, J.J. Neurotoxicity and inflammation in the nasal airways of mice exposed to the macrocyclic trichothecene mycotoxin roridin A: Kinetic and potentiation by bacterial lipipolysaccharide coexposure. Oxford J. Life Sci. Med. Toxicol. Sci. 2007, 98, 526-541.
85. Chang, R.C.; Suen, K.C.; Ma, C.H.; Elyaman, W.; Ng, H.K.; Hugon, J. Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J. Neurochem. 2002, 83, 1215-1225.
86. Ge, Y.; Tsukatani, T.; Nishimura, T.; Furukawa, M.; Miwa, T. Cell death of olfactory receptor neurons in a rat with nasosinusitis infected artificially with Staphylococcus. Chem. Senses 2002, 27, 521-527.
87. Huang, C.C.; Chen, K.; Huang, T.Y. Immunohistochemical studies of sensory neurons in rat olfactory epithelium. Eur. Arch. Otorhinolaryngol. 1995, 252, 86-91.
88. Wu, S.; Kumar, K.U.; Kaufmam, R.J. Identification and requirement of three ribosome binding domains in dsRNA-dependent protein kinase (PKR). Biochemistry 1998, 37, 13816-13826.
89. Garcia, M.A.; Meurs, E.F.; Esteban, M. The dsRNA protein kinase PKR: Virus and cell control. Biochemie 2007, 89, 799-811.
90. Cowan, C.M.; Roskams, A.J. Apoptosis in the mature and developing olfactory neuroepithelium. Microsc. Res. Technol. 2002, 58, 204-215.
91. Farbman, A.I.; Buchholz, J.A.; Suzuki, Y.; Coines, A.; Speert, D. A molecular basis of cell death in olfactory epithelium. J. Comp. Neurol. 1999, 414, 306-314.
92. Suzuki, Y.; Farbman, A.I. Tumor necrosis factor-alpha-induced apoptosis in olfactory epithelium in vitro: Possible roles of caspase 1 (ICE), caspase-2 (ICH-1), and caspase-3 (CPP32). Exp. Neurol. 2000, 165, 35-45.
93. Islam, Z.; Hegg, C.C.; Bae, H.Y.; Pestka, J.J. Satratoxin G-induced apoptosis in PC-12 neuronal cells is mediated by PKR and caspase independent. Toxicol. Sci. 2008, 105, 142-152.
94. Nusuetrong, P.; Yoshida, M.; Tanitsu, M.A.; Kikuchi, H.; Mizugaki, M.; Shimazu, K.; Pengsuparp, T.; Meksuriyen, D.; Oshima, Y.; Nakahata, N. Involvementof reactive oxygen species and stress activated MAPKs in satoratoxin H-induced apoptosis. Eur. J. Pharmacol. 2005, 507, 239-246.
95. Chandra, J.; Samali, A.; Orrenius, S. Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med. 2000, 29, 323-333.
96. Karunasena, E.; Larrañaga, M.D.; Simoni, J.S.; Douglas, D.R.; Straus, D.C. Building-associated neurological damage modeled in human cells: A mechanism of neurotoxic effects by exposure to mycotoxins in the indoor environment. Mycopathologia 2010, 170, 377-390.
97. Thrasher, J.D.; Crawley, S. The biocontaminants and complexity of damp indoor spaces; more than what meets the eyes. Toxicol. Ind. Health 2009, 25, 583-615.
98. Campbell, I.L. Neuropathogenic acions of cytokines assessed in transgenic mice. Int. J. Dev. Neurosci. 1995, 13, 275-284.
99. Peters, A.; Vweronesi, B.; Calderon-Garciduenas, J.; Gehr, P.; Chen, L.C.; Greiser, M.; Reed, W.; Rothen-Rutishauser, B.; Schurch, S.; Schulz, H. Translocation and potential neurological effects of fine and ultrafine particles a critical update. Part. Fibre Toxicol. 2006, 3, 1-13.
100. Calderón-Garcidueñas, L.; Azzarelli, B.; Acuna, H.; Garcia, R.; Gambling, T.M.; Osnaya, N.; Monroy, S.; Tizapantzi, M.D.R.; Carson, J.L.; Villarreal-Calderon, A.; et al. Air pollution and brain damage. Toxicol. Pathol. 2002, 30, 373-389.
101. Calderón-Garcidueñas, L.; Maronpot, R.R.; Torres-Jardon, R.; Henríquez-Roldán, C.; Schoonhoven, R.; Acuña-Ayala, H.; Villarreal-Carderón, A.; Nakamura, J.; Fernando, R.; Reed, W.; et al. DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration. Toxico. Pathol. 2003, 31, 524-538.
102. Dutton, M.F. Fumonisins, mycotoxins of increasing importance: their nature and their effects. Pharmacol. Ther. 1996, 70, 137-161.
103. 1 mice. Environ. Health Perspect. 2001, 109, 277-282.
104. Wang, E.; Norred, W.P.; Bacon, C.W.; Riley, R.T.; Merrill, A.H., Jr. Inhibition of sphingolipid biosynthesis by fumonisins. J. Biol. Chem. 1991, 22, 14486-14490.
105. Merrill, A.H., Jr.; Sullards, M.C.; Wang, E.; Voss, K.A.; Riley, R.T. Sphingolipid metabolism: Role in signal transduction and disruption by fumonisins. Environ. Health Perspect. 2001, 109, 283-289.
106. Riley, R.T.; Enongene, E.; Voss, K.A.; Norred, W.P.; Meredith, F.I.; Sharma, R.P.; Spitsbergen, J.; Williams, D.E.; Carlson, D.B.; Merrill, A.H., Jr. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ. Health Perspect. 2001, 109, 301-308.
107. 1 concentrations in feeds from 45 confirmed equine leukoencephalomalacia cases. J. Vet. Diagn. Invest. 1991, 3, 238-241.
108. 1 levels associated with an epizootics of equine leukoencephalomalacia. J. Vet. Diagn. Invest.1990, 2, 213-216.
109. Goel, S.; Schumacher, J.; Lenz, S.D.; Kemppanien, B.W. Effects of fusarium moniliforme isolates on tissue and serum sphingolipid concentrations in horses. Vet. Hum. Toxicol. 1996, 38, 265-270.
110. Marasas, W.F.; Riley, R.T.; Hendricks, K.A.; Stevens, V.L.; Sadler, T.W.; Gelineau-van Wanes, J. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: A potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J. Nutr. 2004, 134, 711-716.
111. 1-induced neural tube defects by folic acid. Teratology 2002, 66, 169-176.
112. 1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor. J. Biol. Chem. 1997, 272, 18020-18025.
113. Harel, R.; Futerman, A.H. Inhibition of sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons. J. Biol. Chem. 1993, 268, 14476-14481.
114. 1 on primary cultures of rat cerebrum. Neurotoxicol. Teratol. 2000, 22, 565-572.
115. Monnet-Tschudi, F.; Zurich, M.G.; Sorg, O.; Matthieu, J.M.; Honegger, P.; Schilter, B. The naturally occurring food mycotoxin fumonisin B1 impairs myelin formation in aggregating brain cell culture. Neurotoxicology 1999, 20, 41-48.
116. 1 in developing rats alter brain sphinganine levels and myelination. Neurotoxicolog 1997, 18, 571-580.
117. 1-induced increases in neurotransmitter metabolite levels in different brain regions of BALB/c mice. Comp. Biochem. Physiol. C. Pharmacol. Toxicol. Endocrnol. 1998, 120, 457-465.
118. 1. Proc. Soc. Exp. Biol. Med. 1993, 202, 360-364.
119. Banczerowski-Pelyhe, I.; Vilagi, I.; Detri, L.; Doczi, J.; Kovacs, F.; Kukorelli, T. In vivo and in vitro electrophysiological monitoring of rat neocortical activity after dietary fumonisin exposure. Mycopathologia 2002, 153, 149-156.
120. 1-induced neurodegeneration in mice after intracerebroventricular infusion is concurrent with disruption of sphingolipid metabolism and activation of proinflammatory signaling. Neurotoxicology 2005, 26, 211-221.
121. 1 alters the proliferation and the barrier function of porcine intestinal epithelial cells. Toxicol. Sci. 2004, 77, 165-171.
122. 1 alters sphingolipid metabolism and disrupt the barrier function of endothelial cells in culture. Toxicol. Appl. Pharmacol. 1995, 133, 343-348.
123. 1 toxicity in the brain during coexisting lipopolysaccharide-related endotoxemia in BALB/c mice. Toxicol. Sci. 2003, 72, 252-253.
124. Szelenyi, J. Cytokines and the central nervous system. Brain Res. Bull. 2001, 54, 329-338.
125. Buccoliero, R.; Futerman, A.H. The roles of ceramide and complex sphingolipids in neuronal cell function. Pharmacol. Res. 2003, 47, 409-419.
126. Pettus, B.J.; Chalfant, C.E.; Hannun, Y.A. Ceramide in apoptosis: An overview and current perspectives. Biochem. Biophys. Acta 2002, 1585, 114-125.
127. 1 in continuous human and rodent neural cell cultures. Free Radic. Res. 2004, 38, 933-942.
128. 1: cell cycle arrest and DNA base modification in C6 glioma cells. Toxicol. Appl. Pharmacol. 2000, 164, 91-96.
129. 1 in C6 glioma cells. Arch. Toxicol. 2000, 74, 112-119.
130. 1 in rat C6 glioma cells and p53-null mouse embryo fibroblasts. Toxicology 2003, 183, 65-75.
131. 1. Neurochem. Res. 2002, 27, 345-351.
132. 1. Food Chem. Toxicol. 2002, 40, 25-31.
133. Ellerby, L.M.; Ellerby, H.M.; Park, S.M.; Holleran, A.L.; Murphy, A.N.; Fiskum, G.; Kane, D.J.; Testa, M.P.; Kayalar, C.; Bredesen, D.E. Shift of cellular oxidation-reduction potential in neural cells expressing Bcl-2. J. Neurochem.1996, 67, 1259-1267.
134. Kane, D.J.; Sarafian, T.A.; Anton, R.; Hahn, H.; Butler, G.E.; Selverstone, V.J.; Ord, T.; Bredesen, D.E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993, 262, 1274-1277.
135. Tjalkens, R.B.; Ewing, M.M.; Philbert, M.A. Differential cellular regulation of the mitochondrial permeability transition in an in vitro model of 1,3-dinitrobenzene-induced encephalopathy. Brain Res. 2000, 874, 165-177.
136. Reed, J.C.; Meister, L.; Tanaka, S.; Cuddy, M.; Yum, S.; Geyer, C.; Pleasure, D. Differential expression of bcl-2 protooncogene in neuroblastoma and other human tumor cell lines of neuronal origin. Cancer Res. 1991, 51, 6529-6538.
137. 1-induced toxicity and oxidative damage in U-118MG glioblastoma cells. Toxicology 2004, 202, 173-183.
138. 1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases. Toxicol. Appl. Pharmacol.1998, 148, 252-260.
139. Tolleson, W.H.; Dooley, K.L.; Sheldon, W.G.; Thurman, J.D.; Bucci, T.J.; Howard, P.C. The Mycotoxin Fumonisin Induces Apoptosis in Cultured Human Cells and in Livers and Kidneys of Rats. In Advances in Experimental and Medical Biology. Fumonisins in Food; Jackson, L.S., DeVries, J.W., Bullerman, L.B., Eds.; Plenum Press: New York, NY, USA, 1996; pp. 237-250.
140. 1 in human keratinocytes, fibroblasts, esophageal epithelial cells and hepatoma cells. Carcinogenesis 1996, 17, 239-249.
141. Higuchi, Y. Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress. Biochem. Pharmacol. 2003, 66, 1527-1535.
142. Slater, A.F.G.; Nobel, C.S.I.; van den Dobbelsteen, D.J.; Orrenius, S. Signaling mechanisms and oxidative stress in apoptosis. Toxicol. Lett. 1995, 82/83, 149-153.
143. Galtier, P. Pharmacokinetics of ochratoxin A in animals. IARC Sci. Publ. 1991, 187-200.
144. Pfohl-Leszkowicz, A.; Manderville, R.A. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 2007, 51, 61-99.
145. Garies, M.; Wolff, J. Relevance of mycotoxin contaminated feed for farm animals and carryover of mycotoxins to food of animal origin. Mycoses 2000, 43, 79-83.
146. Mally, A.; Hard, G.C.; Dekant, W. Ochratoxin A as a potential etiologic factor in endemic nephropathy: lesions from toxicity studies in rats. Food Chem. Toxicol. 2007, 45, 2254-2260.
147. Krogh, P. Role of ochratoxin in disease causation. Food Chem. Toxicol. 1992, 30, 213-224.
148. Kane, A.; Creppy, E.E.; Roschenthaler, R.; Dirheimer, G. Changes in urinary and renal tubular enzymes caused by subchronic administration of ochratoxin A in rats. Toxicology 1986, 42, 233-243.
149. Petkova-Bocharova, T.; Chernozemsky, I.N.; Castegnaro, M. Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumors in Bulgaria. Food Addit. Contam. 1988, 5, 299-301.
150. Lea, T.; Steinen, K.; Stormer, F.C. Mechanism of ochratoxin A-induced immunosuppression. Mycopathologia 1989, 107, 153-159.
151. Stromer, F.C.; Lea, T. Effects of ochratoxin A upon early and late events in human T-cell proliferation. Toxicology 1995, 95, 45-50.
152. Arora, R.G.; Frolen, H.; Fellner-Feldegg, H. Inhibition of ochratoxin A teratogenesis by zearalenone and diethylstilbesterol. Food Chem. Toxicol. 1983, 21, 779-783.
153. Fukui, Y.; Hayasaka, S.; Itoh, M.; Takeuchi, Y. Development of neurons and synapses in ochratoxin A-induced microcephalic mice: a quantitative assessment of somatosensory cortex. Neurotoxicol. Teratol. 1992, 14, 191-196.
154. Pfohl-Leszkowicz, A.; Chakor, K.; Creppy, E.E.; Dirheimer, G. DNA adduct formation in mice treated with ochratoxin A. IARC Sci. Publ. 1991, 245-253.
155. Sava, V.; Reunova, O.; Velasquez, A.; Harbison, R.; Sanchez-Ramos, J. Acute neurotoxic effects of the fungal netabolite ochratoxin-A. Neurotoxicology 2006, 27, 82-92.
156. Kuiper-Goodman, T.; Hilts, C.; Billiard, S.M.; Kiparissis, Y.; Richard, I.D.; Hayward, S. Health risk assessment of ochratoxin A for all age-sex strata in a market economy. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2010, 27, 212-240.
157. Creppy, E.E.; Chakor, K.; Fisher, M.J.; Dirheimer, G. The mycotoxin ochratoxin A is a substrate for phenylalanine hydroxylase in isolated rat hepatocytes and in vivo. Arch. Toxicol.1990, 64, 279-284.
158. Creppy, E.E.; Kane, D.; Dirheimer, G.; Lafarge-Frayssinet, C.; Mousset, S.; Frayssinet, C. Genotoxicity of ochratoxin A in mice: DNA single-strand break evaluation in spleen, liver and kidney. Toxicol. Lett. 1985, 28, 29-35.
159. Dirheimer, G.; Creppy, E.E. Mechanism of action of ochratoxin A. IARC Sci. Publ. 1991, 171-186.
160. Gautier, J.C.; Holzhaeuser, D.; Markovic, J.; Gremaud, E.; Schilter, B.; Turesky, R.J. Oxidative damage and stress response from ochratoxin exposure in rats. Free Radic. Biol. Med. 2001, 30, 1089-1098.
161. Bryan, N.S.; Rassaf, T.; Maloney, R.E.; Rodriguez, C.M.; Saijo, F.; Rodriguez, J.R.; Feelisch, M. Cellular targets and mechanisms of nitros(yl)ation: An insight into their nature and kinetics in vivo. Proc. Natl. Acad. Sci. USA 2004, 101, 4308-4313.
162. Thomas, J.A.; Mallis, R.J. Aging and oxidation of reactive protein sulfhydryls. Exp. Gerontol. 2001, 36, 1519-1526.
163. Marin-Kuan, M.; Nestler, S.; Verguet, C.; Bezençon, C.; Piguet, D.; Mansourian, R.; Holzwarth, J.; Grigorov, M.; Delatour, T.; Mantel, P.; et al. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin A carcinogenicity in rat. Toxicol. Sci. 2006, 89, 120-134.
164. Aleo, M.D.; Wyatt, R.D.; Schnellmann, R.G. Mitochondrial dysfunction is an early event in ochratoxin A but not oosporein toxicity to rat renal proximal tubules. Toxicol. Appl. Pharmacol. 1991, 107, 73-80.
165. Wei, Y.H.; Lu, C.Y.; Lin, T.N.; Wei, R.D. Effect of ochratoxin A on rat liver mitochondrial respiration and oxidative phosphorylation. Toxicology 1985, 36, 119-130.
166. Belmadani, A.; Tramu, G.; Betbeder, A.M.; Creppy, E.E. Subchronic effects of ochratoxin A on young adult rat brain and partial prevention by aspartate, a sweetener. Hum. Exp. Toxicol. 1998, 17, 380-386.
167. Hayes, A.W.; Cain, J.A.; Moore, B.G. Effects of aflatoxin B1, ochratoxin A and rubratoxin B on infant rats. Food Cosmet. Toxicol. 1977, 15, 23-27.
168. Hayes, A.W.; Hood, R.D.; Lee, H.L. Teratogenic effects of ochratoxin A in mice. Teratology 1974, 9, 93-97.
169. Wangikar, P.B.; Dwivedi, P.; Sharma, A.K.; Sinha, N. Effect in rats of simultaneous prenatal exposure to ochratoxin A and aflatoxin B(1). II. Histopathological features of teratological anomalies induced in fetuses. Birth Defects Res. B 2004, 71, 352-358.
170. Tamura, M.; Hirata, Y.; Matsutani, T. Neurochemical effects of prenatal treatment with ochtatoxin A on fetal and adult mouse brain. Neurochem. Sci. 1988, 13, 1139-1147.
171. Belmadani, A.; Tramu, G.; Betbeder, A.M.; Steyn, P.S.; Creppy, E.E. Regional selectivity to ochratoxin A, distribution and cytotoxicity in rat brain. Arch. Toxicol. 1998, 72, 656-662.
172. Sava, V.; Reunova, O.; Velasquez, A.; Sanchez-Ramos, J. Can low level exposure to ochratoxin-A cause parkinsonism? J. Neurol. Sci. 2006, 249, 68-75.
173. Sanchez-Ramos, J.; Overvik, E.; Ames, B.N. A marker of oxyradical-mediated DNA damage (oxo8dG) is increased in nigro-striatum of Parkinson's disease brain. Neurodegeneration (incorporated into Exp. Neurol.) 1994, 3, 197-204.
174. Bunge, I.; Dirheimer, G.; Roschenthaler, R. In vivo and in vitro inhibition of protein synthesis in Bacillus stearothermophilus by ochratoxin A. Biochem. Biophys. Res. Commun.1978, 83, 398-405.
175. Creppy, E.E.; Kern, D.; Steyn, P.S.; Vleggaar, R.; Roschenthaler, R.; Dirheimer, G. Comparative study of the effect of ochratoxin a analogues on yeast aminoacyl-tRNA synthetases and on the growth and protein synthesis of hepatoma cells. Toxicol. Lett. 1983, 19, 217-224.
176. Palmer, T.D.; Takahashi, J.; Gage, F.H. The adult rat hippocampus contains primordial neural stem cells. Mol. Cell. Neurosci.1997, 8, 389-404.
177. Song, H.J.; Stevens, C.F.; Gage, F.H. Neuronal stem cells from adult hippocampus develop essential properties of functional CNS neurons. Nat. Neurosci. 2002, 5, 438-445.
178. Chen, H.; Tung, Y.C.; Li, B.; Iqbal, K.; Grundke-Iqbal, I. Trophic factors counteract elevated FGF-2-induced inhibition of adult neurogenesis. Neurobiol. Aging 2006, 28, 1148-1162.
179. Kawai, T.; Takagi, N.; Mochizuki, N.; Besshoh, S.; Sakanishi, K.; Nakahara, M.: Takeo, S. Inhibitor of vascular endothelial growth factor receptor tyrosine kinase attenuates cellular proliferation and differentiation to mature neurons in the hippocampal dentate gyrus after transient forebrain ischemia in the adult rats. Neuroscience 2006, 141, 1209-1216.
180. Lagace, D.C.; Yee, J.K.; Bolanos, C.A.; Eisch, A.J. Juvenile administration of methylphenidate attenuates adult hippocampal neurogenesis. Biol. Psychiatry 2006, 60, 1121-1130.
181. Rossi, C.; Angelucci, A.; Costantin, L.; Braschi, C.; Mazzantini, M.; Babbini, F.; Fabbri, M.E.; Tessarollo, L.; Maffei, L.; Berardi, N.; Caleo, M. Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. Eur. J. Neurosci.2006, 24, 1850-1856.
182. Delibas, N.; Altuntas, I.; Yonden, Z.; Ozcelik, N. Ochratoxin A reduces NMDA receptor subunits 2A and 2B concentrations in rat hippocampus: partial protective effect of melatonin. Hum. Exp. Toxicol. 2003, 22, 335-339.
183. Sava, V.; Velasquez, A.; Song, S.; Sanchez-Ramos, J. Adult hippocampal neural stem/progenitor cells in vitro are vulnerable to the mycotoxin ochratoxin A. Toxicol. Sci. 2007, 98, 187-197.
184. Alexander, P. The role of DNA lesions in processes leading to aging in mice. Sym. Soc. Exp. Biol. 1967, 21, 29-50.
185. Korr, H.; Schultz, B. Unscheduled DNA synthesis in various types of cells of the mouse brain in vivo. Exp. Brain Res. 1989, 74, 573-578.
186. Crago, B.R.; Gray, M.R.; Nelson, L.A.; Davis, M.; Arnold, L.; Thrasher, J.D. Psychological, neuropsychological, and electrocortical effects of mixed mold exposure. Arch. Environ. Health 2003, 58, 452-563.
187. Gordon, W.A.; Cantor, J.B. The diagnosis of cognitive impairment associated with exposure to mold. Adv. Appl. Microbiol. 2004, 55, 361-374.
188. Rea, W.J.; Didriksen, N.; Simon, T.R.; Pan, Y.; Fenyves, E.J.; Griffiths, B. Effects of toxic exposure to molds and mycotoxins in building-related illnesses. Arch. Environ. Health 2003, 58, 399-405.
189. Yoon, S.; Cong, W.-T.; Bang, Y.; Lee, S.N.; Yoon, C.S.; Kwack, S.J.; Kang, T.S.; Lee, K.Y.; Choi, J.-K.; Choi, H.J. Proteome response to ochratoxin A-induced apoptotic cell death in mouse hippocampal HT22 cells. Neurotoxicology 2009, 30, 666-676.
190. Sato, A.; Miyazaki, E.; Satake, A.; Hiramoto, A.; Hiraoka, O.; Miyake, T.; Kim, H.S.; Wataya, Y. Proteome and transcriptome analysis of cell death induced by 5-fluoro-2'-deoxyuridine. Nucleic Acids Symp. Ser (Oxf). 2007, 51, 433-434.
191. Siddiq, A.; Ayoub, I.A.; Chavez, J.C.; Aminova, L.; Shah, S.; LaManna, J.C.; Patton, S.M.; Connor, J.R.; Cherny, R.A.; Volitakis, I.; et al. Hypoxia-indicible factor prolyl 4-hydroxylase inhibition. A target for neurprotection in the central nervous system. J. Biol. Chem. 2005, 280, 41732-41743.
192. Lei, T.; He, Q.; Cai, Z.; Zhou, Y.; Wang, Y.; Si, L.; Cai, Z.; Chiu, J.F. Proteomic analysis of chromium cytotoxicity in cultured rat lung epithelial cells. Proteomics 2008, 8, 2420-2429.
193. Noguchi, M.; Takata, T.; Kimura, Y.; Manno, A.; Murakami, K.; Koike, M.; Ohizumi, H.; Hori, S.; Kakizuka, A. ATPase activity of p97/valosin-containing protein is regulated by oxidative modification of the evolutionally conserved cysteine 522 residue in Waker A motif. J. Biol. Chem. 2005, 280, 41332-41341.
194. Zhang, X.; Boesch-Saadatmandi, C.; Lou, Y.; Wolffram, S.; Huebbe, P.; Rimbach, G. Ochratoxin A induces apoptosis in neuronal cells. Genes Nutr. 2009, 4, 41-48.
195. Zurich, M.G.; Lengacher, S.; Braissant, O.; Monnet-Tschudi, F.; Pellerin, L.; Honegger, P. Unusual astrocyte reactivity caused by the food mycotoxin ochratoxin A in aggregating rat brain cell cultures. Neuroscience 2005, 134, 771-782.
196. Hong, J.T.; Lee, M.K.; Park, K.S.; Jung, K.M.; Lee, R.D.; Jung, H.K.; Park, K.L.; Yang, K.J.; Chung, Y.S. Inhibitory effect of peroxisome proliferator-activated receptor gamma agonist on ochratoxin A-induced cytotoxicity and activation of transcription factors in cultured rat embryonic midbrain cells. J. Toxicol. Environ. Health A 2002, 65, 407-418.